[
  {
    "ts": null,
    "headline": "2 Top Dividend Stocks for Growth-Oriented Investors",
    "summary": "Who says you have to choose between the two?",
    "url": "https://finnhub.io/api/news?id=a4320e1c3f14ef6c5a15e58fdf0f3f2882cdcbaabfa4454351255b9f6b8e1efe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763924700,
      "headline": "2 Top Dividend Stocks for Growth-Oriented Investors",
      "id": 137586641,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Who says you have to choose between the two?",
      "url": "https://finnhub.io/api/news?id=a4320e1c3f14ef6c5a15e58fdf0f3f2882cdcbaabfa4454351255b9f6b8e1efe"
    }
  },
  {
    "ts": null,
    "headline": "T. Rowe Price insists investors will find 2026 less stressful",
    "summary": "Maybe you have a big 401(k) account or an Individual Retirement Account. You would be within your rights if you found this week's market volatility — coming just seven months after April's Trump Tariff mini-crash — just a bit unsettling. Is the world about to fall apart? No, say ...",
    "url": "https://finnhub.io/api/news?id=08cfa5bea84246500603e4036f17bf2e0edaa40cc720913f417119f48668fbef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763919653,
      "headline": "T. Rowe Price insists investors will find 2026 less stressful",
      "id": 137587046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Maybe you have a big 401(k) account or an Individual Retirement Account. You would be within your rights if you found this week's market volatility — coming just seven months after April's Trump Tariff mini-crash — just a bit unsettling. Is the world about to fall apart? No, say ...",
      "url": "https://finnhub.io/api/news?id=08cfa5bea84246500603e4036f17bf2e0edaa40cc720913f417119f48668fbef"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?",
    "summary": "The obesity drug producer has taken some hits throughout the past year, but it is beginning to punch back.",
    "url": "https://finnhub.io/api/news?id=9607d690269eb9bf1fc63e175862c7403036dd1b4921dc91da5e3a772c2d4bb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763890200,
      "headline": "Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?",
      "id": 137586703,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The obesity drug producer has taken some hits throughout the past year, but it is beginning to punch back.",
      "url": "https://finnhub.io/api/news?id=9607d690269eb9bf1fc63e175862c7403036dd1b4921dc91da5e3a772c2d4bb1"
    }
  }
]